FDA – medicarereport.org

(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs

FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs

(Source – www.hhs.gov) WASHINGTON— OCTOBER 29, 2025 — The U.S. Food and Drug Administration (FDA) today announced significant action to

(By: Alexandra Murphy for Becker’s Hospital Review) Here are six new drug shortages and discontinuations, according to drug supply databases

(By: Alexandra Murphy for Becker’s Hospital Review) The FDA is moving to scale back its long-standing use of expert panels

(By: Paige Twenter for Becker’s Hospital Review) Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1

(By: Alexandra Murphy for Becker’s Hospital Review) Here are seven new drug shortages and discontinuations, according to drug supply databases

(By: Alexandra Murphy for Becker’s Hospital Review) Draeger has recalled its SafeStar and TwinStar breathing system filters due to a

(By: Alexandra Murphy for Becker’s Hospital Review) Drugmaker Sun Pharma pledged sweeping reforms after years of persistent safety violations at

(By: Alexandra Murphy for Becker’s Hospital Review) Here are seven new drugs and discontinuations, according to drug supply databases from

(By: Alexandra Murphy for Becker’s Hospital Review) While the total number of drug shortages in the U.S. appears to be decreasing